AJ

American Journal of Cardiovascular Drugs

American Journal of Cardiovascular Drugs promotes rational therapy within cardiology and covers all aspects of the treatment of cardiovascular disorders, with particular emphasis on the place in therapy of newer and established agents. The journal publishes reviews and original clinical research on pharmacology, efficacy, adverse effects, newly developed drugs and drug classes, therapeutic implications of research into cardiovascular disease aetiology, and practical management of specific clinical situations.

Looking to publish in American Journal of Cardiovascular Drugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Cardiac & Cardiovascular Systems, Pharmacology & Pharmacy
Impact Factor 3
Quartile Q2
Open Access Type Hybrid
ISSN 1175-3277
eISSN 1179-187X
Invitation Only No
Cost Range Open access APC: £3090.00 GBP / $4990.00 USD / €3990.00 EUR; subscription option: no APC.

Submission Instructions

American Journal of Cardiovascular Drugs accepts the following article types. Click on an article type to view submission instructions.

Review Article

Cover Letter A covering letter is required with the submission. The covering letter must state the article type, explain why the paper is important and of interest to the journal’s readership, and briefly describe what the review covers.
Abstract An abstract is required. Abstract must be 150 to 250 words. Abstract must be unstructured and contain no headings.
Manuscript Review Article manuscripts should be up to 8000 words. A section entitled 'Declarations' must be provided before the reference list. The manuscript must include two to three non-technical Key Points beneath the abstract, a Declarations section with all listed subsections including 'Not applicable' where needed, documentation of any Large Language Model use in the Methods section or another suitable section, a statement identifying who conceived the article, performed the literature search and data analysis, and drafted and critically revised the work, and a disclosure statement.
References There is no limit on the number of references. References must be cited in the text using numbers in square brackets and listed consecutively in a numbered reference list that includes only cited published or accepted works, with full DOI links where available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, but large figures may be submitted separately if file size causes upload problems. Figures and tables must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by concise captions, with figure captions included in the manuscript text file.
Reformat to American Journal of Cardiovascular Drugs using Livewrite Premium

Therapy In Practice Reviews

Cover Letter A covering letter is required. The covering letter must state the article type, explain the paper’s importance and relevance to the journal’s readership, and briefly describe what the review covers.
Abstract An abstract is required. Abstract must be 150 to 250 words. Abstract must be unstructured and contain no headings.
Manuscript Manuscript should be up to 5000 words, excluding the abstract, references, figure legends, and table captions. The manuscript must include a Declarations section and, for this review article type, use an unstructured abstract. The manuscript must include two to three non-technical Key Points beneath the abstract, a disclosure statement, and a statement of responsibility specifying each author’s contribution.
References There is no limit on the number of references. References must use numbered citations in square brackets. The reference list must contain only cited published or accepted works, be numbered consecutively, and include full DOI links where available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, although large figures may be uploaded separately if file size causes problems. Figures and tables must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by concise captions, with figure captions included in the manuscript text file.
Reformat to American Journal of Cardiovascular Drugs using Livewrite Premium

Systematic Review

Cover Letter A covering letter is required with the submission. The covering letter must state the article type, explain why the paper is important and of interest to the journal’s readership, and briefly describe the review’s content or findings.
Abstract An abstract is required. The abstract must be 150 to 250 words, but for some Systematic Review articles it may be increased up to 450 words if needed for full compliance with relevant reporting guidelines. The abstract should be structured.
Manuscript Systematic Review manuscripts should be up to 10,000 words. The manuscript must include two to three short non-technical key points beneath the abstract, a Declarations section with the required subsections, documentation of any Large Language Model use in the Methods or another suitable section, a statement of responsibility specifying every author’s contribution, and a disclosure statement.
References There is no limit on the number of references. Citations must use numbered references in square brackets and the reference list must be numbered consecutively and include full DOI links where available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, but large figures should be submitted separately if file size causes upload problems. Each figure and table must be numbered in Arabic numerals, cited in consecutive numerical order in the text, and accompanied by a caption.
Reformat to American Journal of Cardiovascular Drugs using Livewrite Premium

Original Research Articles

Cover Letter A covering letter is required with the submission. The covering letter must state the article type, explain why the paper is important and of interest to the readership, and briefly describe what was found in the study.
Abstract A structured abstract is required. Abstract must be 150 to 250 words, but for some Original Research Articles it may be increased to 450 words if needed for full compliance with relevant reporting guidelines. Abstract must be structured.
Manuscript Original Research Articles should be up to 6000 words. Manuscripts reporting original research should use titles and subtitles that describe the intervention, methodology, or setting rather than the study results. The manuscript must include two to three non-technical Key Points beneath the abstract, a Declarations section with required subsections, documentation of any Large Language Model use in the Methods or another suitable section, a disclosure statement, and a Data Availability Statement explaining how to access supporting data.
References There is no limit on the number of references. Citations must use numbered references in square brackets. The reference list must contain only cited published or accepted works, be numbered consecutively, and include full DOI links where available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, although large figures may be submitted separately if file size causes upload problems. Tables and figures must be numbered in Arabic numerals and cited in consecutive numerical order, with each table and figure accompanied by a caption and figure captions included in the manuscript text file rather than the figure file.
Reformat to American Journal of Cardiovascular Drugs using Livewrite Premium

Comprehensive Narrative Reviews

Cover Letter A cover letter is required with submission. The cover letter must state the article type, explain why the paper is important and of interest to the journal’s readership, and briefly describe what the review covers.
Abstract An abstract is required. The abstract must be 150 to 250 words. The abstract must be unstructured and contain no headings.
Manuscript The manuscript must include Key Points beneath the abstract, a Declarations section, a disclosure statement, documentation of any Large Language Model use in the manuscript, and a statement of responsibility specifying each author's contribution.
References There is no limit on the number of references. Citations must use numbered references in square brackets. The reference list must include only cited published or accepted works, be numbered consecutively, and include full DOI links when available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, with large figures submitted separately only if file size causes upload problems. Tables and figures must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by captions, with figure captions included in the manuscript text file.
Reformat to American Journal of Cardiovascular Drugs using Livewrite Premium

Letter To The Editor

Cover Letter A cover letter is required with the submission. The cover letter must state the article type, explain why the paper is important and of interest to the journal’s readership, and briefly describe what the review covers or what the study found.
Abstract An abstract is required. The abstract must be 150 to 250 words.
Manuscript Letter To The Editor manuscripts should be up to 1000 words. A section entitled 'Declarations' must be included. Provide two to three short Key Points beneath the abstract in non-technical language, include a 'Declarations' section with the listed subsections and 'Not applicable' where needed, and document any use of a Large Language Model in the Methods section or another suitable section if no Methods section is available.
References There is no limit on the number of references. Citations must use numbered references in square brackets. The reference list must include only cited published or accepted works, be numbered consecutively, and include full DOI links when available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, but large figures may be uploaded separately if file size causes problems. Tables and figures must be numbered in Arabic numerals and cited in consecutive numerical order, with a caption provided for each.
Reformat to American Journal of Cardiovascular Drugs using Livewrite Premium

Adis Drug Reviews

Cover Letter A covering letter is required. The covering letter must state the article type, explain why the paper is important and of interest to the journal’s readership, and briefly describe what the review covers.
Abstract An abstract is required. The abstract must be 150 to 250 words. The abstract must be unstructured and contain no headings.
Manuscript The manuscript must include Key Points beneath the abstract, a Declarations section, a disclosure statement, a statement of responsibility specifying each author's contribution, and documentation of any Large Language Model use in the Methods section or another suitable section if no Methods section is available.
References There is no limit on the number of references. References must use numbered citations in square brackets. The reference list must include only cited published or accepted works, be numbered consecutively, and include full DOI links when available.
Figures & Tables There is no limit on the number of figures or tables. Figures should be submitted within the body of the text, but large figures may be submitted separately if file size causes upload problems. Tables and figures must be numbered with Arabic numerals in consecutive order, and each must include a caption in the manuscript text file.
Reformat to American Journal of Cardiovascular Drugs using Livewrite Premium

Recent Publications

Comment on “Polypill Strategy: A Paradigm Shift in Cardiovascular Disease Prevention”

Frank A. Snyder, Daniel T. Gregory, Roy A. Stimits, Stephan D. Glenn

10.1007/s40256-026-00804-w
View Publication

Spironolactone or Finerenone for Cardiovascular and Kidney Protection in Patients with Moderate CKD?

Panagiotis I. Georgianos, Eirini Leptokaridou-Mourtzila, Christodoula Kourtidou, Ioannis Kontogiorgos, Athanasios Roumeliotis, Vasilios Vaios, Vassilios Liakopoulos

10.1007/s40256-026-00802-y
View Publication

Author’s Reply to: “Comment on: Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials Including 31,397 Subjects Worldwide”

Hoi-Ying Li, Joseph Cheriyan, Tsz-Kwan Chan, Kai-Hang Yiu, Hung-Fat Tse, Ian B. Wilkinson, Yap-Hang Chan

10.1007/s40256-026-00800-0
View Publication

Comment on: “Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide”

Sunil Konipineni, Jayesh Valecha, Caroline Ducatti Meme, Amanda Cyntia Lima Fonseca Rodrigues

10.1007/s40256-026-00801-z
View Publication

Factors Influencing Physician Adherence to Venous Thromboembolism Risk Assessment Model Recommendations: A Best–Worst Scaling

Nicola B. Campoamor, Benjamin G. Mittman, Stephanie Moss, Michael B. Rothberg, John F. P. Bridges

10.1007/s40256-026-00799-4
View Publication

Frequently asked questions

How long does it take to publish?

Manuscripts undergo initial editorial appraisal, external peer review, copy editing, proof review, and online first publication after receipt of corrected proofs.

Reformat to American Journal of Cardiovascular Drugs using Livewrite Premium

Is a cover letter required?

A covering letter is required at submission and should state the article type, why the paper is important, what the review or study covers or found, why it would interest the journal’s readership, and any other pertinent information. Previous editorial or referee comments from prior submissions should be provided when applicable.

Reformat to American Journal of Cardiovascular Drugs using Livewrite Premium

What are the publication costs?

Open access APC is £3090.00 GBP / $4990.00 USD / €3990.00 EUR. Subscription publication has no APC. Open access or subscription is chosen after acceptance.

Reformat to American Journal of Cardiovascular Drugs using Livewrite Premium

Research Topics

Atrial Fibrillation Management and Outcomes Lipoproteins and Cardiovascular Health Antiplatelet Therapy and Cardiovascular Diseases Heart Failure Treatment and Management Blood Pressure and Hypertension Studies Acute Myocardial Infarction Research Venous Thromboembolism Diagnosis and Management Diabetes Treatment and Management Diabetes, Cardiovascular Risks, and Lipoproteins Coronary Interventions and Diagnostics Hormonal Regulation and Hypertension Cardiovascular Function and Risk Factors Cardiac electrophysiology and arrhythmias Cardiac Arrhythmias and Treatments Cardiac Imaging and Diagnostics Health Systems, Economic Evaluations, Quality of Life Medication Adherence and Compliance Pharmacology and Obesity Treatment Renin-Angiotensin System Studies Heart rate and cardiovascular health Cardiac pacing and defibrillation studies Pharmaceutical Economics and Policy Cancer, Lipids, and Metabolism Pulmonary Hypertension Research and Treatments Cardiac, Anesthesia and Surgical Outcomes

Related Journals

CP
Clinical Pharmacology & Therapeutics WILEY
PB
Pharmacology Biochemistry and Behavior Elsevier BV
JO
Journal of Molecular and Cellular Cardiology Elsevier BV
ID
Infectious Diseases and Therapy Adis, Springer Healthcare
PR
Pharmacological Research Elsevier BV
JO
Journal of Cardiovascular Emergencies SCIENDO